通过皮肤封闭装置和接介导的专利卵巢关闭后,心房功能
Carmela Tarsia1, Carlo Gaspardone2, Antonella De Santis1
1Division of Cardiology, Sant'Eugenio Hospital, Piazzale dell'Umanesimo 10, Rome 00144, Italy.
European heart journal. Imaging methods and practice
|July 24, 2024
概括
专利卵孔 (PFO) 的合闭合保护了心房功能,与传统的闭合器不同. 这一发现表明,线关闭可能会降低与PFO治疗相关的心房律乱风险.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 心声回声扫描 (Echocardiography) 是一种心声回声扫描.
背景情况:
- 专利圆孔 (PFO) 关闭是一个常见的程序.
- 传统的金属遮蔽器可能会影响心房功能.
- 接介导的PFO闭合是一种新的技术.
研究的目的:
- 为了比较PFO闭合后的心房功能,使用与传统的闭塞器相比.
- 评估PFO闭合方法对左心房和右心房功能的影响.
主要方法:
- 对40名患者进行前性研究 (20名封闭者,20名 suture).
- 在PFO关闭前和1年后的跨胸部心声扫描.
- 斑点追踪分析以评估心房储水池,导管和收缩功能.
主要成果:
- 1年后,封闭组的LA和RA储,管道和收缩功能明显恶化.
- 针组在LA和RA功能指数中没有显著变化.
- P值显示了闭塞组恶化和组稳定性的统计学意义.
结论:
- 通过接介导的PFO闭合可以保持心房功能.
- 金属封闭器与PFO关闭后心房功能受损有关.
- 心房功能的恶化可能会增加心律失常的风险.
相关概念视频
Mitral Valve Prolapse I: Introduction
1.1K
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
1.1K
Mitral Valve Prolapse II: Assessment and Management
1.4K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Mitral Regurgitation I: Introduction
1.3K
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K
Mitral Regurgitation III: Medical Management
689
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
689
Mitral Stenosis I: Introduction
1.8K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Mitral Stenosis III: Medical Management
538
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
538


